Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm.

Sun M, Kang L, Cui Y, Li G.

Open source

DOI
10.3892/etm.2018.6349
Published
2018-06-22
Container
Exp Ther Med
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/etm.2018.6349,
  title = {Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm.},
  author = {Sun M and  Kang L and  Cui Y and  Li G.},
  year = {2018},
  journal = {Exp Ther Med},
  doi = {10.3892/etm.2018.6349},
  url = {https://doi.org/10.3892/etm.2018.6349}
}

RIS

TY  - JOUR
TI  - Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm.
AU  - Sun M
AU  -  Kang L
AU  -  Cui Y
AU  -  Li G.
PY  - 2018
JO  - Exp Ther Med
DO  - 10.3892/etm.2018.6349
UR  - https://doi.org/10.3892/etm.2018.6349
ER  - 

APA

M, S., L, K., Y, C., & G., L. (2018). Application of a novel targeting nanoparticle contrast agent combined with magnetic resonance imaging in the diagnosis of intraductal papillary mucinous neoplasm.. Exp Ther Med. https://doi.org/10.3892/etm.2018.6349

Source records